Mattias Wieloch

Anticoagulation control in Sweden: reports of time in therapeutic range, major bleeding, and thrombo-embolic complications from the national quality registry AuriculA

Mattias Wieloch, Anders Själander, Viveka Frykman et al. · European Heart Journal · 2011 · 262 citations · Full text

Medicine, Cardiology, Hematology +17

Early diagnosis and better rhythm management to improve outcomes in patients with atrial fibrillation: the 8th AFNET/EHRA consensus conference

Renate B. Schnabel, Elena Andreassi Marinelli, Elena Arbelo et al. · EP Europace · 2022 · 178 citations · Full text

Medicine, Cardiology, Clinical Cardiology +7

Triple antithrombotic therapy following an acute coronary syndrome: prevalence, outcomes and prognostic utility of the HAS-BLED score

J. G. Smith, Mattias Wieloch, Sasha Koul et al. · EuroIntervention · 2012 · 85 citations

Medicine, Cardiology, Pharmacotherapy +17

Dynamic risk assessment to improve quality of care in patients with atrial fibrillation: the 7th AFNET/EHRA Consensus Conference

Larissa Fabritz, Harry J.G.M. Crijns, Eduard Guasch et al. · EP Europace · 2020 · 69 citations · Full text

Medicine, Cardiology, Clinical Decision Support +16

The tumor suppressor p53 and its response gene p21WAF1/Cip1 are not markers of neuronal death following transient global cerebral ischemia

Gregor Tomasevic, Fredrik Kamme, P. Stubberöd et al. · Neuroscience · 1999 · 48 citations

Life Sciences, Neuroscience, Oncology +17